Latham & Watkins is advising Lexington, Massachusetts-based Fractyl Health, a metabolic therapeutics company, in a $110 million initial public offering on the Nasdaq. The Latham & Watkins team is led by partners Nathan Ajiashvili, Johan Brigham, Jonathan Sarna and Evan Smith. Goodwin Procter represents the IPO's underwriters, led by BofA Securities, Evercore and Morgan Stanley.
Biotech & Pharmaceuticals
February 05, 2024, 12:03 PM